Jabez Biosciences, Inc., 2025-10-21
An SEC Form D private-offering notice from Cranberry Twp., PA, a $3,000,000 filer-stated offering target in Biotech. Filed 2025-10-21. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Clinical stage oncology biopharmaceutical company developing JBZ-001, a DHODH inhibitor in Phase 1 trials for solid tumors and non-Hodgkin lymphoma.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Also filed for this raise
every source Form D behind this opportunityOther Form D filings from the same week
each with its own page and its own EDGAR source- Nok Therapeutics, Inc., 2025-10-24, Cranberry Twp., PA
- Basking Biosciences, Inc., 2025-10-22, $55M, Cary, NC
- Thoroughcare, Inc., 2025-10-23, $4M, Pittsburgh, PA
- MarvelBiome, Inc., 2025-10-22, $52.5M, Woburn, MA
- Green Cabbage, Inc., 2025-10-21, $12.6M, Warrendale, PA
- Blue Marlin Therapeutics, Inc., 2025-10-21, Charlottesville, VA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.